GlaxoSmithkline Consumer Healthcare Ltd

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 01, 2013, has noted the withdrawal of nomination by Horlicks Limited of Mr.Simon Scarff as the Director of the Company and as the Chairman of the Board w.e.f. close of business hours as on April 30, 2013 & accepted the resignation of Mr.Subodh Bhargava as an elected Director. The Board appointed Ms.Ireena Vittal as a Director of the Company, in the casual vacancy caused by the resignation of Mr.Subodh Bhargava. Pursuant to Article 97A of the Articles of Association, Horlicks Limited has appointed Mr.Subodh Bhargava as a Director on the Board. Further, the Board has appointed Mr.Subodh Bhargava as the Chairman of the Board w.e.f. May 01, 2013.

GlaxoSmithKline Consumer Healthcare Limited has submitted to the Exchange vide letter dated April 23, 2013 a copy of Minutes of the Annual General Meeting of the Company held on April 09, 2013.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the Outcome of Annual General Meeting held on April 09, 2013.

Life Insurance Corporation of India has informed the Exchange vide letter dated February 18, 2013 that "As per the guideline on Institutional Transactions in shares issued by Govt. of India on February 20, 1990, we hereby inform that Life Insurance Corporation of India has sold 16,71,579 equity shares (of face value of Rs.10/- each) of GlaxoSmithkline Consumer Healthcare Ltd. @ Rs.3900/- per share".

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that the Company has fixed Book Closure from March 21, 2013 to April 9, 2013 both days inclusive for the purpose of Dividend and the Annual General Meeting

HSBC Securities and Capital Markets (India) Private Limited has submitted to the Exchange a Copy of post offer opening advertisement under Regulation 18(7) in terms of SEBI (SAST) Regulations, 2011 was published in newspapers on January 16, 2013.

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of Recommendations of the Committee of Independent Director (IDC) on the Open Offer to the Shareholders of Company under Regulation 26(7) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

HSBC Securities & Capital Markets (India) Private Limited has informed the Exchange regarding Voluntary Open Offer by GlaxoSmithKline Pte Ltd ("GSK Pte" or the "Acquirer") along with Horlicks Limited ("Horlicks") and GlaxoSmithKline plc ("GSK plc") in their capacity as persons acting in concert (each entity individually referred to as "PAC" and together referred to as "PACs") with the Acquirer, to the equity shareholders of GlaxoSmithKline Consumer Healthcare Limited (the "Target Company") to acquire 13,389,410 equity shares ("Shares) of Rs. 10/- each representing 31.84% of the total Voting Share Capital of the Target Company @ Rs. 3,900/- (Rupees Three Thousand and Nine Hundred) per equity share (hereinafter referred to as the "Open Offer Price"), pursuant to SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 ("Open Offer").

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of Abstract for appointment and remuneration of Mr. Ramakrishnan Subramanian, Wholetime Director.

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of Minutes of the Annual General Meeting of the Company held on March 22, 2012.

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of the Proceedings of the Annual General Meeting of the Company held on March 22, 2012.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the dividend shall be paid to the entitled Members on or before April 03, 2012.

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of annual declaration/ disclosure forms as received from employees of the Company under SEBI (Prohibition of Insider Trading) Regulations, 1992.

Closure Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Register of Members and Share Transfer Books will remain closed from March 13, 2012 to March 22, 2011, both days inclusive, for the purpose of Dividend and the Annual General Meeting scheduled to be held on March 22, 2012.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on February 06, 2012 has recommended a Dividend at the rate of Rs. 35/- per equity share of Rs. 10 each.

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of presentation which was made on November 29, 2011 by Managing Director to financial analysts.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Board of Directors has re-appointed Mr. Zubair Ahmed as Managing Director of the Company for the period from January 01, 2012 to May 31, 2013 as a Nominee of Horlicks Ltd., the Promoters of the Company. Mr. Zubair Ahmed`s terms of appointment and remuneration are subject to the approval of the shareholders.

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of Minutes of the Annual General Meeting of the Company held on March 29, 2011.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that at the Annual General Meeting of the Company held on March 29, 2011, all the items of business contained in the notice of the Annual General Meeting of the Company were approved by the Members, who : (1) Approved the Audited Balance Sheet and Profit and Loss account for the year ended December 31, 2010 together with the Directors` Report and Auditors Report thereon; (2) Approved and Declared a dividend of Rs. 50.00 per equity share of Rs.10 each for the year ended December 31, 2010; (3) Re-appointed of M/s. PriceWaterhouse, Chartered Accountants, as the Auditors of the Company upto the conclusion of the next Annual General Meeting of the Company.

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of Notice of the Annual General Meeting of the Company to be held on March 29, 2011.

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of disclosure as per SEBI (Prohibition of Insider Trading) Regulations, 1992.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Register of Members and Share Transfer Books will remain closed from March 15, 2011 to March 28, 2011, both days inclusive, for the purpose of Dividend and Annual General Meeting. Further, the Annual General Meeting of the members of the Company will be held on March 29, 2011.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on February 02, 2011 has recommended a Dividend at the rate of Rs. 50 per equity share of Rs.10 each (Dividend of Rs. 25 per equity share and a Special Dividend of Rs. 25 per equity share to celebrate Golden Jubilee of the Company).

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that "On 6th January, 2011 several newspapers carried Articles and interviews around launches of Sensodyne(R) Sensitive Toothpaste by GSK in India. We would like to clarify that the launch has been done by GSK Asia Private Ltd, our Associate Company in India and not by GlaxoSmithKline Consumer Healthcare Ltd. as reported in some newspapers".